Fewer prescriptions filled as economy worsens

Join Our Community of Science Lovers!

This article was published in Scientific American’s former blog network and reflects the views of the author, not necessarily those of Scientific American


The tumbling economy may be making Americans queasy, but they're apparently so worried about their pocketbooks that they're skipping their meds.

“I’ve seen patients today who said they stopped taking their Lipitor, their cholesterol-lowering medicine, because they can’t afford it,” James King, chairman of the American Academy of Family Physicians, tells the New York Times today. “I have patients who have stopped taking their osteoporosis medication.”

The number of prescriptions filled in the U.S. dropped for the first time in a decade, recent data from the tracking service IMS Health shows. Timothy Anderson of Sanford C. Bernstein & Company, a pharmaceutical analyst, told the Times the 2 percent dip is “most likely tied to a worsening economic environment.”

The drop comes after a 72 percent surge in prescriptions from 1997 to 2007 – a trend that that prompted scrutiny of financial relationships between doctors and pharmaceutical companies and criticism of direct-to-consumer ads encouraging ailing Americans to ask their physicians about expensive new drugs.

Drug prices rose by nearly 7 percent each year over the past decade, with the average retail price of an Rx soaring from $35.72 to $69.91, according to the Kaiser Family Foundation.

“Don’t tell my wife, but if I have 30 days’ worth of pills, I’ll usually stretch those out to 35 or 40 days,” Missourian Martin Schwarzenberger, who takes cholesterol medication, told the Times. “You’re trying to keep a house over your head and use your money to pay all your bills.”


On supporting science journalism

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.


(Image by iStockphoto)

 

 

It’s Time to Stand Up for Science

If you enjoyed this article, I’d like to ask for your support. Scientific American has served as an advocate for science and industry for 180 years, and right now may be the most critical moment in that two-century history.

I’ve been a Scientific American subscriber since I was 12 years old, and it helped shape the way I look at the world. SciAm always educates and delights me, and inspires a sense of awe for our vast, beautiful universe. I hope it does that for you, too.

If you subscribe to Scientific American, you help ensure that our coverage is centered on meaningful research and discovery; that we have the resources to report on the decisions that threaten labs across the U.S.; and that we support both budding and working scientists at a time when the value of science itself too often goes unrecognized.

In return, you get essential news, captivating podcasts, brilliant infographics, can't-miss newsletters, must-watch videos, challenging games, and the science world's best writing and reporting. You can even gift someone a subscription.

There has never been a more important time for us to stand up and show why science matters. I hope you’ll support us in that mission.

Thank you,

David M. Ewalt, Editor in Chief, Scientific American

Subscribe